Reshoring Defined: What It Is and Why 2025–2026 Is the Inflection Point
Reshoring is the process of moving manufacturing production, assembly, or sourcing from an overseas location back to the United States. It is the inverse of offshoring — which was the dominant supply chain strategy from roughly 1990 through 2015 — and it is distinct from nearshoring (moving production to nearby countries such as Mexico or Canada) and friendshoring (relocating to geopolitically allied nations such as India, Vietnam, or Taiwan). For a full comparison of these three strategies, see our guide at Nearshoring vs. Reshoring vs. Friendshoring.
The 2025–2026 reshoring wave is unprecedented in scope. Driven by a convergence of 25% Section 301 tariffs on Chinese imports, persistent post-pandemic supply chain fragility, aggressive federal incentive programs under the CHIPS Act and Inflation Reduction Act, and a structural reassessment of extended supply chain risk, US manufacturers are returning domestic production at a rate not seen since World War II. The Reshoring Initiative has documented more than 350,000 jobs announced as reshored or foreign-direct-investment (FDI) related in 2023 alone, a figure that likely understates actual activity given announcement lag.
The overlooked story in every Fortune 500 reshoring announcement is the mid-market manufacturer. When Ford announces a new EV battery plant in Kentucky, or TSMC breaks ground in Arizona, the headlines focus on the OEM. But the operational backbone of domestic supply chains is built by companies with 50 to 500 employees — precision stampers, injection molders, chemical formulators, contract packagers. These manufacturers are the overlooked beneficiaries of megaproject reshoring announcements, and they face capital challenges that no headline addresses. Explore our full Intel Hub for financing frameworks designed for this segment.
This guide covers the full reshoring definition, the history that created the current opportunity, the policy drivers accelerating it, and — critically — what reshoring actually requires in terms of capital, planning, and regulatory navigation for a mid-market US manufacturer. For CFOs specifically modeling the financial dimensions, see our companion article at The True Cost of Reshoring: A CFO's Complete Budget Framework.
Reshoring vs. Nearshoring vs. Friendshoring: The Three-Way Comparison
These three terms are frequently conflated in media coverage, boardroom discussions, and even government policy documents. For a manufacturer making a capital commitment in the range of $2M to $15M, conflating them is a costly mistake. The following table maps the critical decision dimensions across all three strategies.
| Dimension | Reshoring (to US) | Nearshoring (Mexico/Canada) | Friendshoring (India, Vietnam, etc.) |
|---|---|---|---|
| Definition | Return production to US from any offshore location | Move production to geographically adjacent countries | Move production to politically allied nations |
| Key Driver | Tariff avoidance, supply chain control, policy incentives | Labor cost reduction with shorter logistics chain | Diversification away from single-country exposure |
| Labor Cost Profile | Highest (US wage floor + benefits) | Moderate (Mexico ~$4–6/hr vs. US ~$25+/hr) | Low to moderate (Vietnam ~$3–5/hr; India varies by sector) |
| Tariff Exposure | None — full domestic production | Moderate — USMCA rules of origin apply; renegotiation risk | Varies — Section 301 may apply; GSP status fluctuates |
| Timeline to Implement | 18–36 months (full rate production) | 12–24 months | 18–30 months |
| Capital Required | $2M–$15M+ (greenfield); $500K–$5M (brownfield) | $500K–$3M (setup + logistics) | $1M–$5M (facility + compliance + logistics) |
| Federal Incentives Available | Yes — CHIPS Act, IRA 45X, EDA grants, SBA 504 | Limited — no direct US federal reshoring incentive | Limited — some bilateral trade development programs |
| Best Use Case | Defense, semiconductors, EV components, pharma | Labor-intensive assembly, consumer goods | Electronics, textiles, software-adjacent manufacturing |
Understanding which strategy applies to your operation is the prerequisite for every capital conversation. A CFO modeling a nearshoring project to Mexico should not expect access to CHIPS Act incentives. A manufacturer reshoring to Ohio is eligible for incentives a Mexico-based alternative is not. For a deeper decision framework, see Tariffs & the Reshoring Decision Framework 2026.
Federal Tailwinds: The Policy Architecture Driving the 2026 Reshoring Wave
No reshoring analysis is complete without mapping the federal policy infrastructure that has changed the economics of domestic manufacturing since 2022. Three overlapping policy frameworks — the CHIPS and Science Act, the Inflation Reduction Act, and the tariff regime under Sections 232 and 301 — have collectively created the most favorable domestic manufacturing environment in decades.
| Policy Name | Year Active | Who It Helps | Financial Impact (Illustrative) |
|---|---|---|---|
| CHIPS and Science Act | 2022 (funding through 2026+) | Semiconductor fabs, chip equipment manufacturers, R&D | $52B in grants + 25% investment tax credit for qualified property |
| IRA Section 45X Advanced Manufacturing Production Credit | 2023 (permanent) | EV battery, solar panel, wind component, critical mineral manufacturers | Per-unit credit on qualified components; up to $35/kWh for battery cells |
| Section 301 Tariffs (China) | 2018 (expanded 2024–2026) | Any manufacturer competing against Chinese imports | 25–100% tariffs on $370B+ in Chinese goods; eliminates import cost advantage |
| Section 232 Tariffs (Steel/Aluminum) | 2018 (ongoing) | Domestic steel and aluminum producers; downstream fabricators | 25% steel / 10% aluminum tariffs protect domestic mill pricing |
| EDA Build to Scale Program | Annual appropriations | Manufacturing startups and expansion projects in distressed areas | Grants up to $3M per project; requires 1:1 match. See Commerce.gov/EDA |
| SBA 504 Loan Program | Ongoing | Small and mid-market manufacturers purchasing fixed assets | Up to $5.5M (standard); $5.5M additional for energy-efficient projects; 10–25 year terms at below-market fixed rates |
How Tariffs Changed the Math
Section 301 tariffs on Chinese goods — initially 25% across most manufactured goods categories, expanded to 100% on EVs and solar panels in 2024 — fundamentally altered the offshore cost calculus for US importers. A manufacturer importing $10 million annually from Chinese contract suppliers now faces $2.5 million in annual tariff cost, often more than erasing the labor cost differential that motivated offshoring in the first place. For a manufacturer with $40 million in annual Chinese import spend, the annual tariff exposure approaches $10 million — sufficient to fund a significant portion of a domestic facility build-out over a 3–5 year horizon.
IRA 45X: The Production Credit That Changes Break-Even
The Section 45X Advanced Manufacturing Production Credit is, in the view of many manufacturing CFOs, the most transformative incentive in the IRA. Unlike a one-time investment credit, 45X pays a per-unit credit on qualified domestic production indefinitely — as long as production occurs on US soil. For EV battery cell manufacturers, this is worth up to $35 per kilowatt-hour of cells produced. For a facility producing 10 gigawatt-hours annually, that represents $350 million per year in federal credits. For mid-market component suppliers to EV assemblers, the credit flows indirectly through the supply chain economics — OEMs who receive 45X credits can afford to pay domestic suppliers a premium over offshore alternatives. For more on this, see the Capital Access solutions page.
Quick Check
See what you qualify for in under 3 minutes.
No personal guarantee required. No hard credit pull. Revenue history is what qualifies you.
Check Capital Eligibility →Case Simulation: Midwest Plastics Components LLC — Reshoring the Hard Way
Background: Midwest Plastics Components LLC is a hypothetical 85-employee injection molding company located in the Columbus, Ohio metropolitan area. For eight years, the company sourced the majority of its interior trim components for a Tier-1 automotive customer from a Chinese contract manufacturer in Guangdong province. The arrangement worked because the Chinese supplier's unit costs were approximately 28% below what domestic production would have required, and the Tier-1 customer set pricing that reflected the offshore cost baseline.
The Tariff Disruption: With the 2024 expansion of Section 301 tariffs to 25% across automotive interior components, the import cost advantage eroded from 28% to approximately 3% — within the margin of error of freight variance and quality inspection costs. The Tier-1 customer, itself under OEM pressure to localize its supply chain for IRA compliance, began requiring domestic sourcing certification for suppliers receiving new program awards. Midwest Plastics faced a choice: reshore or lose the next program cycle.
The Capital Challenge: Reshoring required investment in 14 new injection molding machines, tooling qualification, and expanded warehouse space — a capital commitment the company's CFO estimated at $4.2 million. The complicating factor was timing: the customer required first domestic delivery within 9 months, but the company's existing $1.2 million revolving line of credit could not support equipment purchases of this scale. Additionally, the company would face a 90-day working capital gap between the last offshore shipment and the first domestic invoice — a period during which payroll and overhead continued without offsetting revenue from the new domestic line.
Solution Structure (Illustrative): The company secured an asset-based lending facility sized against its existing receivables and finished goods inventory to cover operating costs during the transition gap. A separate equipment bridge loan funded the injection molding machines pending the processing of an SBA 504 application for the longer-term fixed-asset financing. The bridge was structured with an 18-month term, interest-only payments for the first 6 months, and takeout at the SBA 504 closing. This combination allowed the company to meet the customer's 9-month domestic sourcing deadline without a material equity injection. All figures are illustrative; actual terms depend on lender review. See our guide to financing a US factory expansion for applicable structures.
Reshoring FAQs: Answers for US Manufacturers
Reshoring specifically refers to returning production that was previously moved overseas back to the United States. Onshoring is a broader term that includes any domestic manufacturing activity, whether or not the work was previously offshored. All reshoring is onshoring, but not all onshoring is reshoring. The distinction matters for policy purposes, as some federal incentives — and certain grant programs — are specifically tied to the return of previously offshored production rather than greenfield domestic investment. Companies that have never offshored production may not qualify for certain "reshoring" incentives even if they are expanding domestic capacity.
According to the Reshoring Initiative, announced reshoring and foreign direct investment job announcements have exceeded 350,000 in recent years, with 2023 and 2024 setting consecutive records. By 2026, cumulative reshored jobs since 2010 are estimated to surpass one million, though the Reshoring Initiative notes that tracking methodology captures announced jobs, not all of which are immediately implemented. Mid-market manufacturers represent a growing share of these announcements, driven by tariff pressures, supply chain disruption costs, and new federal incentive programs under the IRA and CHIPS Act.
Semiconductors, electric vehicle and automotive components, pharmaceuticals, defense and aerospace, and consumer electronics are leading the reshoring wave. Semiconductors have accelerated most dramatically due to the CHIPS and Science Act. Automotive is driven by EV supply chain localization requirements tied to IRA tax credits — buyers of domestically assembled EVs must meet increasing percentages of battery and critical mineral domestic content to qualify for consumer tax credits, which forces OEMs to localize their supply chains. Pharmaceutical reshoring is partly mandate-driven through drug security legislation requiring domestic API production.
On a simple direct labor cost comparison, US domestic production carries a higher unit labor cost than offshore alternatives — this is a factual statement. However, total landed cost analysis often narrows or eliminates this gap when accounting for tariffs, ocean freight (which is significantly elevated post-pandemic), inventory carrying costs, quality control and inspection, lead time risk and safety stock requirements, intellectual property exposure, and supply chain disruption insurance. The Reshoring Initiative's Total Cost of Ownership Estimator, available at reshorenow.org, provides a tool for modeling these factors. For many manufacturers, particularly in tariff-exposed categories, the fully-loaded cost differential has compressed dramatically since 2022.
Key federal programs supporting reshoring include: (1) the CHIPS and Science Act for semiconductor manufacturers — $52B in grants plus a 25% investment tax credit for qualified semiconductor manufacturing property; (2) the IRA Section 45X Advanced Manufacturing Production Credit for EV battery, solar, and wind component producers; (3) Section 232 and 301 tariffs that structurally disadvantage imports in targeted categories; (4) EDA Build to Scale and Regional Challenge grants for manufacturers in distressed areas; (5) SBA 504 loans for fixed asset financing at below-market rates. For a complete listing, see the Commerce Department manufacturing programs page.
Ready to check your options?
Rev Boost Funding connects operators with independent financing partners. Not a lender. Affiliate partnerships present.
Disclaimer: Financial figures and ROI estimates on this page are illustrative only. They are modeled from published research and do not represent guaranteed outcomes. Individual results will vary. See our full disclosure policy.
Check Capital Eligibility →Reshoring Readiness Self-Assessment
This assessment is illustrative only. Actual readiness depends on your specific balance sheet, operational capacity, regulatory situation, and customer requirements. Consult a qualified manufacturing advisor and commercial lender before making reshoring capital commitments.